Theravance Biopharma Inc (TBPH)
9.21
-0.25
(-2.64%)
USD |
NASDAQ |
Apr 23, 16:00
9.215
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Market Cap: 443.84M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 455.64M |
| April 19, 2024 | 449.86M |
| April 18, 2024 | 443.12M |
| April 17, 2024 | 458.53M |
| April 16, 2024 | 466.72M |
| April 15, 2024 | 477.79M |
| April 12, 2024 | 462.86M |
| April 11, 2024 | 430.11M |
| April 10, 2024 | 459.49M |
| April 09, 2024 | 456.60M |
| April 08, 2024 | 456.12M |
| April 05, 2024 | 448.41M |
| April 04, 2024 | 440.23M |
| April 03, 2024 | 447.45M |
| April 02, 2024 | 438.30M |
| April 01, 2024 | 434.93M |
| March 28, 2024 | 432.04M |
| March 27, 2024 | 433.96M |
| March 26, 2024 | 424.81M |
| March 25, 2024 | 421.92M |
| March 22, 2024 | 429.63M |
| March 21, 2024 | 431.56M |
| March 20, 2024 | 433.96M |
| March 19, 2024 | 426.26M |
| March 18, 2024 | 416.62M |
| Date | Value |
|---|---|
| March 15, 2024 | 416.14M |
| March 14, 2024 | 414.70M |
| March 13, 2024 | 423.85M |
| March 12, 2024 | 410.36M |
| March 11, 2024 | 412.77M |
| March 08, 2024 | 415.18M |
| March 07, 2024 | 418.55M |
| March 06, 2024 | 420.96M |
| March 05, 2024 | 417.59M |
| March 04, 2024 | 438.30M |
| March 01, 2024 | 454.67M |
| February 29, 2024 | 456.12M |
| February 28, 2024 | 452.75M |
| February 27, 2024 | 466.72M |
| February 26, 2024 | 444.56M |
| February 23, 2024 | 432.52M |
| February 22, 2024 | 417.19M |
| February 21, 2024 | 421.28M |
| February 20, 2024 | 428.97M |
| February 16, 2024 | 423.20M |
| February 15, 2024 | 416.95M |
| February 14, 2024 | 406.85M |
| February 13, 2024 | 401.56M |
| February 12, 2024 | 412.62M |
| February 09, 2024 | 412.62M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
395.31M
Minimum
Feb 08 2024
1.934B
Maximum
Apr 29 2020
909.40M
Average
759.78M
Median
Mar 10 2022
Market Cap Benchmarks
| Corcept Therapeutics Inc | 2.380B |
| Nektar Therapeutics | 259.82M |
| Vanda Pharmaceuticals Inc | 266.11M |
| Fate Therapeutics Inc | 451.03M |
| FibroGen Inc | 104.70M |
Market Cap Related Metrics
| PS Ratio | 8.879 |
| Price to Book Value | 2.084 |
| Price | 9.21 |
| Earnings Yield | -10.53% |